Share-based Payment Arrangement, Expense in USD of GUIDED THERAPEUTICS INC from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
GUIDED THERAPEUTICS INC quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2011 to Q1 2024.
  • GUIDED THERAPEUTICS INC Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $14.8K, a 86.1% decline year-over-year.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2023 was $236K, a 34.3% increase from 2022.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2022 was $176K, a 23% decline from 2021.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2021 was $228K, a 26.5% decline from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14.8K -$92.2K -86.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q1 2023 $107K +$63.1K +143% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $44K -$18K -29% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022
Q1 2021 $62K 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2014 $298K -$132K -30.7% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014
Q3 2013 $130K -$13K -9.09% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2013
Q1 2013 $430K +$232K +117% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q3 2012 $143K +$47K +49% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q2 2012 $152K +$43K +39.5% 01 Apr 2012 30 Jun 2012 10-Q/A 24 Aug 2012
Q1 2012 $198K 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q3 2011 $96K 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012
Q2 2011 $109K 01 Apr 2011 30 Jun 2011 10-Q/A 24 Aug 2012

GUIDED THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $236K +$60.3K +34.3% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $176K -$52.4K -23% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $228K -$82K -26.5% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2022
2020 $310K 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.